Brody's disease is characterized by a deficiency of Ca2+-ATPase in the sarcoplasmic reticulum of type 2 muscle fibers, explaining the impaired muscle relaxation.
Answers are grounded in this paper and cite their sources.
Confirms type 2 fiber-specific Ca2+-ATPase deficiency in Brody's disease; leaves open therapeutic implications pending larger studies.
Four male patients from two families were first seen with impaired skeletal muscle relaxation that rapidly worsened during exercise. Muscle biopsies from 2 patients were examined by appropriate biochemical and microscopic immunocytochemical techniques. The adenosine triphosphate (ATP)-dependent Ca2+ transport rate was extremely low in a particulate membrane fraction of skeletal muscle, and there was also a marked reduction of the concentration of 100-kD phosphoprotein, corresponding to Ca2+-ATPase of sarcoplasmic reticulum, in muscle microsomes. The concentration of immunoreactive Ca2+-ATPase of sarcoplasmic reticulum was markedly reduced on immunoblots. Evaluation by microscopic immunocytochemical techniques, using one polyclonal and two monoclonal antibodies against sarcoplasmic reticulum Ca2+ transport protein, revealed that the severe reduction of immunoreactive Ca2+-ATPase was limited to the histochemical type 2 fibers. The deficiency of the Ca2+ transport protein in the sarcoplasmic reticulum of type 2 fibers, which may be the primary expression of a presumed gene defect, can explain the impaired muscle relaxation of the patients. This disease appears to be a clinically, electromyographically, and biochemically distinct metabolic myopathy.
No takes yet. Share an insight, caveat, or question.
Karpati et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: